Compare NVO & BAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVO | BAC |
|---|---|---|
| Founded | 1923 | 1784 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.4B | 352.0B |
| IPO Year | 2001 | 2025 |
| Metric | NVO | BAC |
|---|---|---|
| Price | $37.97 | $47.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 25 |
| Target Price | $45.73 | ★ $62.48 |
| AVG Volume (30 Days) | 10.1M | ★ 27.9M |
| Earning Date | 11-04-2026 | 10-14-2026 |
| Dividend Yield | ★ 3.30% | 2.63% |
| EPS Growth | N/A | ★ 18.69 |
| EPS | N/A | ★ 3.23 |
| Revenue | N/A | ★ $113,097,000,000.00 |
| Revenue This Year | $0.47 | $8.30 |
| Revenue Next Year | $0.96 | $6.32 |
| P/E Ratio | ★ $13.60 | $15.03 |
| Revenue Growth | N/A | ★ 11.00 |
| 52 Week Low | $35.12 | $46.12 |
| 52 Week High | $64.16 | $65.23 |
| Indicator | NVO | BAC |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 28.13 |
| Support Level | $37.61 | $46.12 |
| Resistance Level | $39.64 | $53.61 |
| Average True Range (ATR) | 1.00 | 1.15 |
| MACD | -0.23 | -0.07 |
| Stochastic Oscillator | 2.31 | 2.93 |
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Bank of America is a formidable financial titan with a $3.43 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.